Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

T. Kauf · SciRah

Researcher profile · Semantic Scholar

T. Kauf

Share profile

T. Kauf — researcher profile on SciRah

h-index: 19
Works: 76
Citations: 1,618

Most-cited papers

The cost of health care for children and adults with sickle cell disease
T. Kauf, Thomas D. Coates, Hua-Zhi Liu, N. Mody-Patel +1 more
2009American journal of hematology/oncology435 citations Open access
Semantic Scholar
The burden of hepatitis C virus infection in children: estimated direct medical costs over a 10-year period.
Ravi R. Jhaveri, William C. Grant, T. Kauf, J. Mchutchison
2006Jornal de Pediatria108 citations
Semantic Scholar
Cost-effectiveness of respiratory syncytial virus prophylaxis in various indications.
C. Hampp, T. Kauf, A. Saidi, A. Winterstein
2011Archives of Pediatrics & Adolescent Medicine95 citations
Semantic Scholar
Trends in health care resource use for hepatitis C virus infection in the United States
William C. Grant, Ravi R. Jhaveri, J. Mchutchison, K. Schulman +1 more
2005Hepatology89 citations Open access
Semantic Scholar
Factors associated with initiation and completion of human papillomavirus vaccine series among young women enrolled in Medicaid.
R. Cook, Jian-Yi Zhang, J. Mullins, T. Kauf +3 more
2010Journal of Adolescent Health85 citations
Semantic Scholar
The cost of acute myocardial infarction in the new millennium: evidence from a multinational registry.
T. Kauf, E. Velazquez, D. Crosslin, W. Weaver +8 more
2006American Heart Journal78 citations
Semantic Scholar
Alvimopan, a peripherally acting μ-opioid receptor antagonist, is associated with reduced costs after radical cystectomy: economic analysis of a phase 4 randomized, controlled trial.
T. Kauf, R. Svatek, G. Amiel, Timothy L. Beard +14 more
2014Journal of Urology67 citations
Semantic Scholar
Cost-utility analysis of rimonabant in the treatment of obesity.
C. Hampp, A. Hartzema, T. Kauf
2006Value in Health64 citations Open access
Semantic Scholar
HIV Antiretroviral Treatment: Early Versus Later
J. Mauskopf, M. Kitahata, T. Kauf, A. Richter +1 more
2005Journal of Acquired Immune Deficiency Syndromes64 citations
Semantic Scholar
A predictive model of health state utilities for HIV patients in the modern era of highly active antiretroviral therapy.
T. Kauf, N. Roskell, A. Shearer, B. Gazzard +3 more
2008Value in Health58 citations Open access
Semantic Scholar
Economic Efficiency of Genetic Screening to Inform the Use of Abacavir Sulfate in the Treatment of HIV
T. Kauf, R. Farkouh, S. Earnshaw, M. Watson +2 more
2012PharmacoEconomics (Auckland)52 citations
Semantic Scholar
Spillover adherence effects of fixed-dose combination HIV therapy
T. Kauf, Keith L. Davis, S. Earnshaw, E. Davis
2009Patient Preference and Adherence31 citations Open access
Semantic Scholar
Women's Willingness to Accept Perceived Risks for Vasomotor Symptom Relief
F. Johnson, Semra Özdemir, Brett Hauber, T. Kauf
2007Journal of Women's Health29 citations
Semantic Scholar
Systematic review and network meta-analysis of tedizolid for the treatment of acute bacterial skin and skin structure infections caused by MRSA
R. McCool, I. Gould, J. Eales, T. Barata +4 more
2017BMC Infectious Diseases28 citations Open access
Semantic Scholar
ASSESSMENT OF RESPONSE SHIFT USING TWO STRUCTURAL EQUATION MODELING TECHNIQUES
P. Gandhi, L. Ried, I-Chan Huang, Carole L. Kimberlin +1 more
2012Quality of Life Research28 citations Open access
Semantic Scholar
Inhibitor clinical burden of disease: a comparative analysis of the CHESS data
A. Oladapo, Mei Lu, S. Walsh, J. O'Hara +1 more
2018Orphanet Journal of Rare Diseases27 citations Open access
Semantic Scholar
Psoriasis patients’ willingness to accept side-effect risks for improved treatment efficacy
T. Kauf, Jui-Chen Yang, A. Kimball, M. Sundaram +5 more
2015Journal of dermatological treatment (Print)27 citations
Semantic Scholar
An open-label, pragmatic, randomized controlled clinical trial to evaluate the comparative effectiveness of daptomycin versus vancomycin for the treatment of complicated skin and skin structure infection
T. Kauf, P. Mckinnon, G. Corey, John P. Bedolla +10 more
2015BMC Infectious Diseases21 citations Open access
Semantic Scholar
Factors influencing the participation of gastroenterologists and hepatologists in clinical research
A. Dev, T. Kauf, A. Zekry, K. Patel +3 more
2008BMC Health Services Research19 citations Open access
Semantic Scholar
Incorporating Problem-Based Learning Concepts into a Lecture-based Pharmacoeconomics Course
Y. Shih, T. Kauf, A. Biddle, K. Simpson
1999American Journal of Pharmaceutical Education17 citations
Semantic Scholar
Economic Impact of Alvimopan Considering Varying Definitions of Postoperative Ileus.
S. Earnshaw, T. Kauf, Cheryl McDade, Michele H. Potashman +3 more
2015Journal of the American College of Surgeons16 citations
Semantic Scholar
Methodological Concerns with Economic Evaluations of Meningococcal Vaccines
T. Kauf
2012PharmacoEconomics (Auckland)16 citations
Semantic Scholar
Price discrimination and bargaining power in the U.S. vaccine market: Implications for childhood immunization policy
T. Kauf
199915 citations
Semantic Scholar
Patients' willingness to accept the risks and benefits of new treatments for chronic hepatitis C virus infection.
T. Kauf, A. Mohamed, A. Hauber, Derek Fetzer +1 more
2012Patient14 citations
Semantic Scholar
Vaccine-associated liability risk and provider immunization practices.
Gary L. Freed, T. Kauf, V. Freeman, Donald E. Pathman +1 more
1998Archives of Pediatrics & Adolescent Medicine14 citations Open access
Semantic Scholar
Trends in the prevalence of thrombocytopenia among individuals iInfected with hepatitis C Virus in the United States, 1999-2008
T. Kauf, D. Nelson, J. Schelfhout, J. A. Delaney +1 more
2012BMC Research Notes13 citations Open access
Semantic Scholar
Economic evaluation of everolimus vs. azathioprine at one year after de novo heart transplantation
Jasmina I. Radeva, S. Reed, Z. Kaló, T. Kauf +3 more
2005Clinical Transplantation13 citations Open access
Semantic Scholar
Cost-effectiveness of ceftolozane/tazobactam compared with piperacillin/tazobactam as empiric therapy based on the in-vitro surveillance of bacterial isolates in the United States for the treatment of complicated urinary tract infections
T. Kauf, V. Prabhu, G. Medic, Rebekah H. Borse +4 more
2017BMC Infectious Diseases12 citations Open access
Semantic Scholar
Impact of disease severity and gastrointestinal side effects on the health state preferences of patients with osteoarthritis.
Jane Chang, T. Kauf, S. Mahajan, J. M. Jordan +6 more
2005Arthritis & Rheumatism10 citations
Semantic Scholar
Validity of laboratory-based surveillance for detection of respiratory syncytial virus seasons.
C. Hampp, N. Asal, E. Lipowski, T. Kauf +3 more
2013American Journal of Epidemiology8 citations
Semantic Scholar
Influence of explanatory and confounding variables on health-related quality of life after controlling for measurement bias and response shift in measurement
P. Gandhi, L. Ried, Carole L. Kimberlin, T. Kauf +1 more
2013Expert review of pharmacoeconomics & outcomes research7 citations Open access
Semantic Scholar
Patients’ Willingness to Accept the Risks and Benefits of New Treatments for Chronic Hepatitis C Virus Infection
T. Kauf, A. Mohamed, A. Hauber, Derek Fetzer +1 more
2012Patient6 citations Open access
Semantic Scholar
Economic Burden of Sickle Cell Disease among Children and Adults.
A. Hartzema, T. Kauf, T. Coates, Hua-Zhi Liu +1 more
20075 citations
Semantic Scholar
Compact Quadruple Therapy with the Lamivudine/Zidovudine Combination Tablet Plus Abacavir and Efavirenz, Followed by the Lamivudine/Zidovudine/Abacavir Triple Nucleoside Tablet Plus Efavirenz in Treatment-Naïve HIV-Infected Adults
P. Ruane, D. Parenti, D. Margolis, D. Shepp +8 more
2003HIV Clinical Trials5 citations Open access
Semantic Scholar
Use of Home Health Care by ESRD and Medicare Beneficiaries
T. Kauf, Y. Shih
1999Health Care Financing Review5 citations
Semantic Scholar
Cost-effectiveness of ceftolozane/tazobactam plus metronidazole versus piperacillin/tazobactam as initial empiric therapy for the treatment of complicated intra-abdominal infections based on pathogen distributions drawn from national surveillance data in the United States
V. Prabhu, J. Solomkin, G. Medic, J. Foo +5 more
2017Antimicrobial Resistance and Infection Control4 citations Open access
Semantic Scholar
A Descriptive Comparison of Disease Burden Between Hemophilia Patients with and without Inhibitors: Data from the CHESS Study
A. Oladapo, S. Walsh, J. O'Hara, T. Kauf
20163 citations
Semantic Scholar
Cost Implications of Tedizolid use in acute Bacterial Skin and Skin Structure Infection (Absssi) for Hospitals and Managed care Organizations (Mcos)
T. Kauf, P. Xu, M. Živković, F. Corvino
20153 citations Open access
Semantic Scholar
Small budget impact is a result of flawed assumptions and ignores questionable cost-effectiveness for RSV prophylaxis.
C. Hampp, T. Kauf, A. Winterstein
2010Value in Health3 citations Open access
Semantic Scholar
What is the Government's Perspective
T. Kauf
1999Medical decision making3 citations
Semantic Scholar
Turning the spotlight on experimental design in discrete choice experiments-a focus on pragmatic approaches in health.
J. Whitty, T. Kauf
2013Value in Health2 citations Open access
Semantic Scholar
Trends in the prevalence of thrombocytopenia among individuals iInfected with hepatitis C Virus in the United States, 1999-2008
T. Kauf, D. Nelson, J. Schelfhout, Joseph A. Delaney +1 more
2012BMC Research Notes2 citations Open access
Semantic Scholar
The greater estimated expense associated with USGFNAB may still be a reasonable expenditure to achieve an additional correct diagnosis, but that is for individual practices and providers to decide.
T. Kauf
2010Head and Neck2 citations
Semantic Scholar
PRS17 COST-EFFECTIVENESS OF RESPIRATORY SYNCYTIAL VIRUS PROPHYLAXIS WITH PALIVIZUMAB FROM THE PERSPECTIVE OF A SOUTHERN US MEDICAID AGENCY
C. Hampp, T. Kauf, A. Saidi, A. Winterstein
20092 citations Open access
Semantic Scholar
Reconciling Decision Models With the Real World
Y. Shih, T. Kauf
1999PharmacoEconomics (Auckland)2 citations
Semantic Scholar
Economic assessment of three antimicrobial therapies for uncomplicated urinary tract infection in women.
Xing-Yu Huang, A. Hartzema, R. Raasch, T. Kauf +1 more
1999Clinical Therapeutics2 citations
Semantic Scholar
Systematic Review and Network Meta-Analysis of Tedizolid for the treatment of acute Bacterial Skin and Skin Structure Infection (Absssi) Due to Methicillin-Resistant Staphylococcus Aureus (Mrsa)
R. McCool, J. Eales, T. Barata, M. Arber +5 more
20151 citations Open access
Semantic Scholar
Progression of Platelet Counts in Treatment Naïve HIV/HCV Co-Infection *
J. Schelfhout, D. Stojanovic, A. Houtchens, H. Crane +8 more
20131 citations Open access
Semantic Scholar
Methodological Concerns Regarding Cost-effectiveness Analysis of Palivizumab in Florida Medicaid-Reply.
C. Hampp, T. Kauf, A. Saidi, A. Winterstein
2012Archives of Pediatrics & Adolescent Medicine1 citations
Semantic Scholar
PCV111 IDENTIFICATION OF RESPONSE SHIFT AMONG HYPERTENSIVE PATIENTS WITH CORONARY ARTERY DISEASE USING TWO STRUCTURAL EQUATION MODELING TECHNIQUES
P. Gandhi, L. Ried, I-Chan Huang, C. Kimberlin +2 more
20111 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

C. Hampp×6
Invite
C. Hampp — researcher profile on SciRah
A. Winterstein×5
Invite
A. Winterstein — researcher profile on SciRah
A. Hartzema×4
Invite
A. Hartzema — researcher profile on SciRah
J. Mchutchison×3
Invite
J. Mchutchison — researcher profile on SciRah

×3

Invite

A. Saidi — researcher profile on SciRah

Invite

K. Schulman — researcher profile on SciRah

Invite

S. Earnshaw — researcher profile on SciRah

Invite

P. Gandhi — researcher profile on SciRah

Invite

L. Ried — researcher profile on SciRah

I-Chan Huang×3

Invite

I-Chan Huang — researcher profile on SciRah

Invite

Y. Shih — researcher profile on SciRah

J. Schelfhout×3

Invite

J. Schelfhout — researcher profile on SciRah